A Glimpse into the AI-Driven Advances in Neurobiology and Neurologic Diseases

Wu Qiu,Hulin Kuang

DOI: https://doi.org/10.3390/biomedicines12061221

IF: 4.757

2024-05-31

Biomedicines

Abstract:Recent developments in AI, especially in machine learning and deep learning, have opened new avenues for research and clinical practice in neurology [...]

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

What problem does this paper attempt to address?

The paper attempts to address the issue of exploring the advancements in the application of Artificial Intelligence (AI) in neurobiology and the research and clinical practice of neurological diseases. Specifically, the paper focuses on the following aspects:

1. **Advanced Diagnostic Techniques**: Utilizing AI-driven methods to improve the accuracy of diagnosing neurological diseases, such as identifying ischemic regions in stroke patients through Convolutional Neural Network (CNN) models and predicting the histological grading of meningiomas from Magnetic Resonance Imaging (MRI) scans.

2. **Enhanced Predictive Models**: Developing machine learning techniques to predict the progression of diseases, such as dementia and epilepsy. By analyzing large datasets and using complex algorithms (such as Support Vector Machines and deep learning), these studies provide predictive models that may enable earlier and more accurate interventions.

3. **Therapeutic Applications and Treatment Planning**: Demonstrating the potential of AI in supporting treatment planning and intervention strategies, such as using hybrid CNN and transformer networks to guide the real-time management of stroke patients' treatment.

4. **Automated Systems to Enhance Clinical Efficiency**: Discussing the role of AI in automating clinical processes, such as identifying behavioral activities of epilepsy patients and detecting neurological abnormalities. These automated systems aim to improve clinical efficiency and the level of patient monitoring.

5. **Neural Mechanisms and Disease Biomarkers**: The application of AI is not limited to the clinical level but also includes basic research fields, helping to elucidate underlying disease mechanisms and discover new biomarkers. For example, using AI to analyze Electroencephalogram (EEG) patterns and neuroimaging data to gain deeper insights into brain function and disorders.

In summary, this paper brings together the results of multiple research fields, showcasing the wide-ranging applications of AI in neurobiology and the management of neurological diseases. It also points out the directions for future exploration, including improving the accuracy, reliability, and applicability of AI models, as well as addressing related ethical issues.